Jayesh M D Patel: Platelet-Rich Plasma and Ovarian Reactivation in Postmenopausal Women
Jayesh M D Patel, APSF Social Ambassador, Specialist Anaesthetist at Jayesh Patel Anaesthetic Services Limited, shared Ratanak Roth Oeurn – Kent‘s post on LinkedIn, adding:
“In the news:
Endocrinologists have achieved the complete reversal of menopause in post-menopausal women, restoring fully functional ovarian cycles, natural hormone profiles, and confirmed ovulation in women aged 45 to 62.
In a trial of 290 post-menopausal women, a 97% success rate was recorded in restoring measurable follicular activity within 12 weeks, with 34 participants achieving natural pregnancies within 6 months — the oldest being 59 years old.
The treatment involves injecting platelet-rich plasma (PRP) combined with a proprietary mitochondrial activator directly into ovarian tissue, reawakening dormant primordial follicles that had ceased activity.
This triggers the hypothalamic-pituitary-ovarian axis back into full hormonal rhythm — restoring estradiol, progesterone, FSH, and LH to levels comparable to a 28-year-old woman.
Beyond fertility, patients reported elimination of hot flashes, restoration of bone density, and dramatic improvements in cognitive clarity.
Menopause has just been reclassified from an inevitability to a reversible biological state.
Take note TeWhatuOra.
Are you really a centre of excellence?
If you don’t measure you cant improve!
How can you improve if you dont know!
Respect our patients’ most important organ!
Monitor the target organ!
Ditch surrogate cardiovascular parameters in guiding anaesthesia!!!
Practice scientifically.
Practice objectively administer analgesia scientifically, use advanced nociception monitoring.
Superior to any anaesthesiologist!!!”
Title: Persistent Opioid Use After Hospital Admission From Surgery in New Zealand: A Population-Based Study
Authors: Jiayi Gong, Peter Jones, Chris Frampton, Kebede Beyene, Amy Hai Yan Chan
Read the Full Article on Anesthesia and Analgesia

Title: Outcomes Related to New Persistent Opioid Use After Surgery or Trauma: A Population-based Cohort Study
Authors: Jiayi Gong, Peter Jones, Kebede Beyene, Chris Frampton, Amy Hai Yan Chan
Read the Full Article on Annals of Surgery

Ratanak Roth Oeurn – Kent, Founder, Chairman, CEO at WORLD NEWS 24/7, shared a post on LinkedIn:
“In the news:
A biological miracle is happening in elite longevity and reproductive clinics, where endocrinologists have achieved what biology previously declared impossible — the complete reversal of menopause in post-menopausal women, restoring fully functional ovarian cycles, natural hormone profiles, and confirmed ovulation in women aged 45 to 62.
In a trial of 290 post-menopausal women, a 97% success rate was recorded in restoring measurable follicular activity within 12 weeks, with 34 participants achieving natural pregnancies within 6 months — the oldest being 59 years old.
The treatment involves injecting platelet-rich plasma (PRP) combined with a proprietary mitochondrial activator directly into ovarian tissue, reawakening dormant primordial follicles that had ceased activity.
This triggers the hypothalamic-pituitary-ovarian axis back into full hormonal rhythm — restoring estradiol, progesterone, FSH, and LH to levels comparable to a 28-year-old woman.
Beyond fertility, patients reported elimination of hot flashes, restoration of bone density, and dramatic improvements in cognitive clarity.
Menopause has just been reclassified from an inevitability to a reversible biological state.”
Stay updated with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS